State of Wisconsin Investment Board’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.89M | Buy |
121,987
+4,244
| +4% | +$247K | 0.02% | 852 |
|
|
2025
Q4 | $7M | Buy |
117,743
+5,534
| +5% | +$301K | 0.02% | 857 |
|
|
2025
Q3 | $6.08M | Sell |
112,209
-7,788
| -6% | -$445K | 0.01% | 872 |
|
|
2025
Q2 | $6.6M | Sell |
119,997
-29,222
| -20% | -$1.72M | 0.02% | 823 |
|
|
2025
Q1 | $10.5M | Buy |
149,219
+22,781
| +18% | +$1.53M | 0.03% | 602 |
|
|
2024
Q4 | $8.31M | Sell |
126,438
-14,456
| -10% | -$968K | 0.02% | 742 |
|
|
2024
Q3 | $9.9M | Buy |
140,894
+10,292
| +8% | +$860K | 0.02% | 661 |
|
|
2024
Q2 | $10.8M | Buy |
130,602
+30,201
| +30% | +$2.51M | 0.03% | 543 |
|
|
2024
Q1 | $8.77M | Sell |
100,401
-16,175
| -14% | -$1.45M | 0.02% | 695 |
|
|
2023
Q4 | $11.2M | Buy |
116,576
+4,745
| +4% | +$420K | 0.03% | 547 |
|
|
2023
Q3 | $9.89M | Buy |
111,831
+8,578
| +8% | +$763K | 0.03% | 569 |
|
|
2023
Q2 | $8.95M | Buy |
103,253
+4,735
| +5% | +$446K | 0.03% | 660 |
|
|
2023
Q1 | $9.58M | Buy |
98,518
+5,319
| +6% | +$551K | 0.03% | 610 |
|
|
2022
Q4 | $9.65M | Sell |
93,199
-11,419
| -11% | -$1.07M | 0.03% | 590 |
|
|
2022
Q3 | $8.87M | Sell |
104,618
-24,399
| -19% | -$2.17M | 0.03% | 619 |
|
|
2022
Q2 | $10.7M | Sell |
129,017
-4,830
| -4% | -$385K | 0.03% | 609 |
|
|
2022
Q1 | $10.3M | Sell |
133,847
-88,707
| -40% | -$7.42M | 0.02% | 772 |
|
|
2021
Q4 | $19.7M | Buy |
222,554
+134,875
| +154% | +$11.1M | 0.04% | 485 |
|
|
2021
Q3 | $6.78M | Buy |
87,679
+6,298
| +8% | +$497K | 0.01% | 930 |
|
|
2021
Q2 | $6.79M | Sell |
81,381
-33,700
| -29% | -$2.67M | 0.01% | 946 |
|
|
2021
Q1 | $8.69M | Sell |
115,081
-69,424
| -38% | -$5.67M | 0.02% | 804 |
|
|
2020
Q4 | $16.2M | Buy |
184,505
+75,341
| +69% | +$5.97M | 0.04% | 480 |
|
|
2020
Q3 | $8.3M | Sell |
109,164
-27,910
| -20% | -$2.82M | 0.02% | 705 |
|
|
2020
Q2 | $16.9M | Buy |
137,074
+7,580
| +6% | +$753K | 0.05% | 397 |
|
|
2020
Q1 | $10.9M | Sell |
129,494
-24,522
| -16% | -$2.11M | 0.04% | 478 |
|
|
2019
Q4 | $13M | Buy |
154,016
+97,710
| +174% | +$7.38M | 0.03% | 553 |
|
|
2019
Q3 | $3.79M | Sell |
56,306
-9,591
| -15% | -$739K | 0.01% | 886 |
|
|
2019
Q2 | $5.64M | Sell |
65,897
-27,046
| -29% | -$2.31M | 0.02% | 793 |
|
|
2019
Q1 | $8.26M | Sell |
92,943
-691
| -0.7% | -$64K | 0.02% | 683 |
|
|
2018
Q4 | $7.97M | Sell |
93,634
-23,540
| -20% | -$2.24M | 0.03% | 623 |
|
|
2018
Q3 | $11.4M | Sell |
117,174
-45,135
| -28% | -$4.51M | 0.03% | 581 |
|
|
2018
Q2 | $15.3M | Sell |
162,309
-101,262
| -38% | -$8.87M | 0.04% | 443 |
|
|
2018
Q1 | $21.4M | Buy |
263,571
+171,994
| +188% | +$14.8M | 0.06% | 335 |
|
|
2017
Q4 | $8.17M | Buy |
91,577
+40,970
| +81% | +$3.56M | 0.02% | 713 |
|
|
2017
Q3 | $4.71M | Sell |
50,607
-29,876
| -37% | -$2.64M | 0.01% | 858 |
|
|
2017
Q2 | $7.31M | Sell |
80,483
-31,250
| -28% | -$2.84M | 0.02% | 699 |
|
|
2017
Q1 | $9.81M | Buy |
111,733
+18,281
| +20% | +$1.63M | 0.04% | 518 |
|
|
2016
Q4 | $7.74M | Sell |
93,452
-15,903
| -15% | -$1.37M | 0.03% | 571 |
|
|
2016
Q3 | $10.1M | Buy |
109,355
+1,300
| +1% | +$122K | 0.04% | 509 |
|
|
2016
Q2 | $8.41M | Sell |
108,055
-6,000
| -5% | -$510K | 0.03% | 562 |
|
|
2016
Q1 | $9.41M | Sell |
114,055
-4,730
| -4% | -$385K | 0.04% | 538 |
|
|
2015
Q4 | $12.4M | Sell |
118,785
-930
| -0.8% | -$97.1K | 0.05% | 423 |
|
|
2015
Q3 | $12.6M | Sell |
119,715
-3,390
| -3% | -$453K | 0.05% | 431 |
|
|
2015
Q2 | $16.8M | Buy |
123,105
+3,730
| +3% | +$462K | 0.06% | 384 |
|
|
2015
Q1 | $14.9M | Buy |
119,375
+5,530
| +5% | +$586K | 0.05% | 429 |
|
|
2014
Q4 | $10.3M | Sell |
113,845
-3,500
| -3% | -$291K | 0.04% | 541 |
|
|
2014
Q3 | $8.47M | Sell |
117,345
-9,280
| -7% | -$610K | 0.03% | 601 |
|
|
2014
Q2 | $7.88M | Sell |
126,625
-2,750
| -2% | -$166K | 0.03% | 662 |
|
|
2014
Q1 | $8.82M | Buy |
129,375
+130
| +0.1% | +$9.58K | 0.03% | 621 |
|
|
2013
Q4 | $9.08M | Buy |
129,245
+27,030
| +26% | +$1.84M | 0.03% | 586 |
|
|
2013
Q3 | $7.38M | Sell |
102,215
-7,920
| -7% | -$526K | 0.03% | 653 |
|
|
2013
Q2 | $6.14M | Buy |
+110,135
| New | +$6.86M | 0.03% | 715 |
|
Other funds holding BMRN
VCM
VPM
State of Wisconsin Investment Board's BMRN Position: Q1 2026 in Review
State of Wisconsin Investment Board increased its BioMarin Pharmaceuticals (BMRN) stake by 3.6% in Q1 2026, buying an estimated $247K and bringing the position to 121,987 shares worth $6.89M. The position accounts for 0.02% of the portfolio, ranked #852.
State of Wisconsin Investment Board first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.4M in Q1 2018. 556 funds tracked by Wall St. Rank hold BMRN as of Q1 2026.
- State of Wisconsin Investment Board held 121,987 shares of BioMarin Pharmaceuticals worth $6.89M as of Q1 2026.
- State of Wisconsin Investment Board bought 4,244 BioMarin Pharmaceuticals shares in Q1 2026, an estimated $247K.
- BioMarin Pharmaceuticals made up 0.02% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #852 holding.
- State of Wisconsin Investment Board first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- State of Wisconsin Investment Board's BioMarin Pharmaceuticals position peaked at $21.4M in Q1 2018.
- 556 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.